Cargando…
Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis
INTRODUCTION: Famotidine is a competitive histamine H2-receptor antagonist most commonly used for gastric acid suppression but thought to have potential efficacy in treating patients with Coronavirus disease 2019 (COVID-19). The aims of this systematic review and meta-analysis are to summarize the c...
Autores principales: | Chiu, Leonard, Shen, Max, Lo, Chun-Han, Chiu, Nicholas, Chen, Austin, Shin, Hyun Joon, Prsic, Elizabeth Horn, Hur, Chin, Chow, Ronald, Lebwohl, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568101/ https://www.ncbi.nlm.nih.gov/pubmed/34735523 http://dx.doi.org/10.1371/journal.pone.0259514 |
Ejemplares similares
-
Colchicine use in patients with COVID-19: A systematic review and meta-analysis
por: Chiu, Leonard, et al.
Publicado: (2021) -
The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis
por: Chow, Ronald, et al.
Publicado: (2021) -
Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature
por: Chow, Ronald, et al.
Publicado: (2021) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)